BioCryst Pharmaceuticals, Inc. (BCRX)
8.12
-0.17
(-2.05%)
USD |
NASDAQ |
Sep 11, 16:00
8.11
-0.01
(-0.12%)
After-Hours: 20:00
BioCryst Pharmaceuticals Market Cap : 2.073B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.073B |
| September 10, 2026 | 2.116B |
| September 09, 2026 | 2.248B |
| September 08, 2026 | 2.314B |
| September 04, 2026 | 2.542B |
| September 03, 2026 | 2.576B |
| September 02, 2026 | 2.596B |
| September 01, 2026 | 2.532B |
| August 31, 2026 | 2.476B |
| August 28, 2026 | 2.507B |
| August 27, 2026 | 2.519B |
| August 26, 2026 | 2.509B |
| August 25, 2026 | 2.509B |
| August 24, 2026 | 2.471B |
| August 21, 2026 | 2.438B |
| August 20, 2026 | 2.466B |
| August 19, 2026 | 2.571B |
| August 18, 2026 | 2.476B |
| August 17, 2026 | 2.537B |
| August 14, 2026 | 2.486B |
| August 13, 2026 | 2.504B |
| August 12, 2026 | 2.703B |
| August 11, 2026 | 2.639B |
| August 10, 2026 | 2.512B |
| August 07, 2026 | 2.394B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.374B |
| August 05, 2026 | 2.315B |
| August 04, 2026 | 2.302B |
| August 03, 2026 | 2.249B |
| July 31, 2026 | 2.281B |
| July 30, 2026 | 2.347B |
| July 29, 2026 | 2.421B |
| July 28, 2026 | 2.474B |
| July 27, 2026 | 2.433B |
| July 24, 2026 | 2.372B |
| July 23, 2026 | 2.383B |
| July 22, 2026 | 2.416B |
| July 21, 2026 | 2.393B |
| July 20, 2026 | 2.314B |
| July 17, 2026 | 2.360B |
| July 16, 2026 | 2.313B |
| July 15, 2026 | 2.390B |
| July 14, 2026 | 2.474B |
| July 13, 2026 | 2.517B |
| July 10, 2026 | 2.654B |
| July 09, 2026 | 2.723B |
| July 08, 2026 | 2.822B |
| July 07, 2026 | 2.792B |
| July 06, 2026 | 2.583B |
| July 02, 2026 | 2.499B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 204.00B |
| Halozyme Therapeutics, Inc. | 12.23B |
| Neurocrine Biosciences, Inc. | 15.87B |
| Vertex Pharmaceuticals, Inc. | 130.59B |
| Agenus, Inc. | 295.75M |
Market Cap Related Metrics
| PS Ratio | 2.043 |
| PEG Ratio | -0.0071 |
| Price to Free Cash Flow | 5.394 |
| Price | 8.12 |
| Earnings Yield | -18.52% |
| PEGY Ratio | -0.0071 |
| Operating PE Ratio | 4.996 |
| Normalized PE Ratio | 14.54 |